Remove tag molecular-partners
article thumbnail

Almirall and IRB Barcelona team up to tackle skin disease

pharmaphorum

Almirall and IRB Barcelona (the Institute for Research in Biomedicine), will conduct research using molecular glue degraders, a new approach to the skin diseases under scrutiny. This is where molecular glue degraders come in. It also builds on complementary core expertise of each partner to facilitate research and drug development.”.

article thumbnail

Targeting a human protein may stop Ebola virus in its tracks

The Pharma Data

This special enzyme, once fused to Ebola virus polymerase, enables the polymerase to add a molecular tag to any other protein it interacts with. By fishing out proteins that contain this unique tag, researchers could map out the complex series of Ebola virus polymerase-host protein interactions.

Protein 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Beam makes USD 120M bet; GRAIL and Quest announce the collaboration; Brain organoids mimic infant’s brains; Improvement in T cells to kill cancer

Delveinsight

Earlier, the prescription-only blood test will only be available through partner health systems, medical practices, and self-insured employers. Two genes were activated to improve the T cells’ ability to eradicate cancer cells, as reported in the journal Molecular Cell.

DNA 52
article thumbnail

Women in Science Who Have Paved the Way Forward in Genetics

XTalks

Geneticist Martha Chase was a key partner of the foundational Hershey-Chase experiment that helped confirm DNA to be the carrier of genetic information; however, it was only Hershey of the pair that went on to win the Nobel Prize in Physiology or Medicine in 1969 for the discovery. Marie Maynard Daly: Breaking Barriers.

Genetics 119
article thumbnail

Roche’s quantitative COVID-19 antibody test; Janssen buys a gene therapy asset; Zimmer Acquires A&E Medical; Glaucoma research study: Merck chooses TriNKET cancer immunotherapy program; Ovid fails Angelman phase 3 study

Delveinsight

The antibody test has proved to be very accurate in the 15 days after screening and diagnosis of active infection with a molecular test, agreeing with positive PCR results 96.6% The platform is planned for enabling Bayer to make its expertise and resources accessible to its partners while preserving their autonomy and culture.

article thumbnail

Pharma By The Numbers: A Retrospective Look at the Industry and 20 Years of Xtalks History

XTalks

No matter how you’re looking to communicate your expertise in the life sciences, your audience is already here, so contact us to become an Xtalks partner. New Drug Approvals Are on the Rise In 2002, the FDA approved a combined total of 17 New Molecular Entities (NMEs) and Biologics License Applications (BLAs).